Find the latest pharmaceutical market place for formulations enquiry about Nivolumab on PharmaCompass.com.

Various Finished Dosage Formulations needed in Romania [ENA17932]

A large pharmaceutical company based in India that devotes itself to R&D, production, marketing and sales of active pharmaceutical ingredients and pharmaceutical intermediates is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The suppliers must support this enquiry with EUGMP & EUCTD dossier.
1. Nicergoline (10 mg or 30 mg) Capsules
2. Nivolumab (10 mg/ ml) Injections
3. Carbamazepine (200 mg) Tablets
4. Sulodexide (25 mg) Capsules

Reply

31 Aug 2023

Tender// Various Finished Dosage Formulations needed in Poland [ENA17012]

Zespol Opieki Zdrowotnej is looking for supplies of Various Finished Dosage Formulations for commercial purposes. The deadline is 31-May-2023.
1. Nivolumab (10 mg/ ml) Solution for Injections or Infusions. The required quantity is 60,000 units.
2. Ipilimumab (5 mg/ ml) Injections. The required quantity is 6,000 units.

Reply

02 May 2023

Various Finished Dosage Formulations needed in Brazil [ENA16235]

A company that deals in the research, development & trading of health products is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The suppliers must support this enquiry with CTD Dossier.
1. Pembrolizumab (100 mg) Injections
2. Paclitaxel (6 mg, 30 mg, 100 mg, 150 mg & 300 mg) Injections
3. Nivolumab (40 mg & 100 mg) Injections
4. Oxaliplatin (5 mg, 50 mg & 100 mg) Injections
5. Bevacizumab (25 mg) Injections

Reply

28 Jan 2023

Various Finished Dosage Formulations needed in Brazil [ENA12424]

A company that deals in the research, development & trading of health products is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with CTD Dossier, ANVISA, DMF & PIC/s GMP.
1. Semaglutide (4 mg in 3 ml & 2 mg in 1.5 ml) Prefilled Syringes. The required quantity is 1 million units & 500,000 units respectively.
2. Liraglutide (6 mg in 3 ml & 6 mg in 2 ml) Prefilled Syringes. The required quantity is 1 million units for each.
3. Paclitaxel (100 mg in 16.7 ml & 300 mg in 50 ml) Prefilled Syringes. The required quantity is 5 million units for each.
4. Rivaroxaban (20 mg, 15 mg & 10 mg) Coated Tablets. The required quantity is 100 million units, 80 million units & 70 million units respectively.
5. Nivolumab (100 mg in 10 ml & 40 mg in 4 ml) IV Solution. The required quantity is 200 million units & 100 million units respectively.

Reply

17 Jan 2022

Tender// Various Finished Dosage Formulations needed in Estonia [ENA09367]

Sihtasutus Tartu Ülikooli Kliinikum is looking for supplies of Various Finished Dosage Formulations. The suppliers must support this tender with ESPD. The deadline is 25-Jan-2021.
1. Pertuzumab (420 mg) Concentration for Infusion. The required quantity is 450 units.
2. Pembrolizumab (100 mg) Powder for solution for Injection. The required quantity is 2,000 units.
3. Nivolumab (240 mg/ 24 ml) Concentration for Infusion. The required quantity is 480 units.
4. Obinutuzumb (1000 mg) Concentration for Infusion. The required quantity is 100 units.
5. Siponimodum (2 mg) Tablets. The required quantity is 1,000 units.
6. Upadacitinib (15 mg) Tablets. The required quantity is 2,000 units.

Reply

29 Dec 2020

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.